Using knotless implants for hip capsule closure during surgery
Official title: Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
Run by American Hip Institute · NCT06500364 · Data updated 2026-11-12
This study tests if a new knotless device for closing the hip capsule during surgery can help patients recover better than traditional knotted sutures.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | American Hip Institute Academic / other |
| Locations | 1 site (Des Plaines, Illinois) |
| Status | Recruiting |
| Started | October 29, 2024 |
| Main results expected | August 2025 |
| Study ends | August 2027 |
| Registry record updated | January 1, 2025 |
| Trial ID | NCT06500364 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients under 60 years old who are scheduled for primary hip arthroscopy and will receive capsular closure with the LoopLocTM device.
✕Probably not a fit
Patients who have had previous hip surgery or significant cartilage damage may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of the Arthrex LoopLocTM device for closing the hip capsule during primary hip arthroscopy compared to traditional knotted sutures. The hip capsule, which stabilizes the hip joint, is cut during surgery and needs to be repaired afterward. The LoopLocTM device is designed to minimize irritation and scar tissue formation, potentially leading to improved patient outcomes. Participants will be monitored for two years to assess their recovery and overall results from the surgery.
Why it matters
Potential benefit: If successful, this approach could lead to reduced pain and better recovery outcomes for patients undergoing hip arthroscopy.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving surgical outcomes with alternative closure techniques.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing a primary hip arthroscopy * Patients younger than 60 years old. * Patients who will receive capsular closure with the Arthrex LoopLocTM device following hip arthroscopy. Exclusion Criteria: * Patients that had previous hip surgery, * Patients that had a center edge angle (CEA) less than 25 degrees or greater than 40 degrees. * Patients that have a cartilage damage grade greater than or equal to 3.
Where it's running
-
American Hip Institute Research Foundation
Des Plaines, Illinois, United States Recruiting
Study contacts
- Study coordinator: Alexandra Mantice
- Email: alexandra.mantice@americanhipinstitute.org
- Phone: 8338724477
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of PRP, PPP, and BMAC on recovery after hip surgery for labral issues
This study is testing whether treatments like platelet-rich plasma and bone marrow concentrate can help people recover better after hip surgery for labral issues.
-
Education and exercise program for hip and groin pain relief
This study is testing a new education and exercise program for people with long-term hip and groin pain to see if it helps them feel better compared to regular care.
-
Comparing acetabular anteversion in patients with femoro-acetabular impingement and healthy volunteers
This study is testing how the angle of the hip socket differs between people with hip pain from femoro-acetabular impingement and healthy individuals in various positions.
-
Using bone marrow concentrate with hip arthroscopy for labral tears and impingement
This study is testing whether using bone marrow concentrate during hip surgery can help people with labral tears and hip impingement feel better and prevent further joint problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.